Pfizer launches biosimilar drug for breast cancer in PHL market


Headlines / Headlines 142 Views comments

BIOPHARMACEUTICAL firm Pfizer just lately introduced a trastuzumab biosimilar as an reasonably priced choice for Filipinos in search of remedy for an aggressive sort of breast most cancers.   The biosimilar, accepted this March by the Food and Drug Administration...